4-hydroxy-2,2,6,6-tetramethyl-1-hydroxypiperidine
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 18, 2011 (NCT01324141)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 4-hydroxy-2,2,6,6-tetramethyl-1-hydroxypiperidine
- 4-hydroxy-tempo
- 4-hydroxy-tempo
- 4-hydroxy-tempo
- 4-hydroxy-tempol
- hotmp
- n-hydroxy-2,2,6,6-tetramethylpiperidine
- ot-674
- tempo-h
- tempol-h
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01324141 | Phase 1 | Mar 18, 2011 | National Cancer Institute (NCI) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2011 |
1 organizations
Page 1 / 1